PVP Ventures name change to Evervie Health: 2026 checklist

What PVP Ventures has announced

PVP Ventures Ltd, a listed company in the Real Estate Developers industry under the Real Estate/Construction sector, has approved a proposal to change its name to “Evervie Health Limited”, subject to shareholder approval. The update signals a possible repositioning in the company’s identity, but the renaming will only take effect after regulatory and shareholder processes are completed.

Alongside the proposed name change, the company has appointed Ms. Saloni Khandelwal, Dr. Ellen Feehan, and Mr. Srivatsan Kalyanasundaram as Additional Non-Executive Independent Directors. The appointments add independent representation on the board at a time when the company is also dealing with compliance filings and corporate actions.

The company’s listed identifiers referenced in the disclosure include BSE Code 517556, NSE Symbol PVP (also shown as PVPEQ in the provided market snapshot), and ISIN INE362A01016. The stated current price is ₹40.20, and the stated market capitalisation is ₹1046.82.

Board appointments: what is confirmed

The announcement states that three individuals have been appointed as Additional Non-Executive Independent Directors. No tenure, committee roles, or effective-date details are provided in the text beyond the appointment itself. Still, the designation is specific: “additional,” “non-executive,” and “independent,” which typically implies the directors are not part of day-to-day management and are expected to provide oversight and governance.

Because the proposed renaming is subject to shareholder approval, board oversight and governance documentation usually become more visible to investors. However, the disclosure provided does not include any explanation for the appointments or how they link to the name-change proposal.

Name change: shareholder approval is still pending

The company has approved a change in its name to “Evervie Health Limited,” but it is explicitly subject to shareholder approval. That means the company will need to take the proposal to shareholders, typically through an AGM or EGM resolution, before the new name can be implemented in corporate records and exchange systems.

The material also notes that name-change compliance requires meeting regulatory conditions and securing approvals from the exchange and the registrar before finalising the listed entity’s new name. This is important because, for a listed company, a name change is not only a branding exercise. It affects trading symbols, exchange records, shareholder communications, and in some cases may require updates to share certificates and depository records.

Regulation 45: conditions highlighted in the disclosure

The text summarises Regulation 45 requirements for a listed entity seeking a name change. Two points stand out.

First, the listed entity must satisfy a time condition: at least one year must have elapsed since the last name change. Second, the proposed name must reflect the entity’s activities by meeting either a revenue test or an investment test. The revenue test described is that at least 50% of the prior year revenue should be from the new activity suggested by the new name. The investment test described is that investment in the new activity should be at least 50% of the assets of the listed entity.

The disclosure also states that name availability must be obtained from the ROC (Registrar of Companies), and the stock exchange approval must be supported by certifications from the company secretary and from practicing chartered accountants or statutory auditors.

Exchange and ROC paperwork: what a typical checklist covers

The text includes an outline-style checklist describing what documents are required at different stages.

For in-principle approval, the exchange documentation includes an application for name change, a certified copy of the board resolution, the date of last name change (if applicable), a reason for the name change, and a confirmation from the company secretary that the Regulation 45 conditions are met (one-year time elapsed and either the 50% revenue test or 50% investment test). It also calls out confirmation of name availability from ROC, a request for symbol change (not exceeding 10 characters), and applicable fees and tax.

For final approval, the list includes confirmation of name change from ROC, shareholder meeting notice and resolution, a fresh certificate of incorporation consequent on the change of name, amended memorandum and articles, and the process for effecting the name change in share certificates (issuing new certificates, affixing stickers, or rubber-stamping) along with confirmation that old share certificates remain valid for delivery.

Compliance filing: SEBI DP Regulation 74(5) certificate

Separately, the content includes a compliance communication titled “Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.” The company states it enclosed a certificate issued by KFin Technologies Limited, the registrar and share transfer agent, confirming compliance under Regulation 74(5) for the quarter ended 30 September 2025.

The KFin certificate is dated 07 October 2025 and states that details of securities dematerialised and rematerialised during the period have been furnished to all stock exchanges where the shares are listed, as required under the regulation. The company communication is signed by Mr. Prasad V. Potluri, Chairman and Managing Director, and references the enclosure received from KFin.

Corrigendum on auditor certificate for asset book value

The text also mentions: “Corrigendum to the Independent Auditors Certificate on Book value of Asset of the company for the Quarter ending on 30th June, 2025.” No further details are provided in the supplied content about what was corrected, the magnitude of the change (if any), or the context for the corrigendum.

Still, the mention is relevant because book value of assets is frequently referenced in corporate compliance processes, including those linked to investment tests and disclosure practices. Without additional numbers or narrative in the text, the only confirmed point is that a corrigendum exists and relates to the quarter ended 30 June 2025.

Corporate background: earlier names and incorporation timeline

The company’s corporate history is described in the text. It states that the entity was formerly incorporated on January 1, 1994 as Software Solution Integrated Private Limited. It then became a public limited company on May 10, 1995, and the name was changed to Software Solution Integrated Limited. Later, the name was changed to PVP Ventures Limited on June 03, 2008.

This timeline matters because Regulation 45 includes a one-year condition since the last name change. The text does not state whether any name change occurred after June 2008, only that June 03, 2008 was a name-change point.

Market snapshot and identifiers in the disclosure

The provided content includes market and identifier references, including price, market cap, codes, and symbols. These details are often used by investors to cross-verify the company and track exchange filings.

Why the announcement matters for investors

Two separate threads run through the disclosure: corporate actions and routine compliance. The name-change proposal is a corporate action that requires shareholder approval and multiple regulatory steps, and the Regulation 45 summary in the text underlines that the exchange and ROC process is rule-driven, not discretionary.

At the same time, the Regulation 74(5) certificate is part of ongoing depository compliance, which helps ensure that demat and remat activity records are properly reported to the exchanges. The inclusion of the KFin certificate details and dates provides investors with a documented compliance trail for the quarter ended 30 September 2025.

Closing summary

PVP Ventures has approved a proposed rename to Evervie Health Limited, pending shareholder approval, and has appointed three additional non-executive independent directors. The disclosure also points to the Regulation 45 framework for name changes, including the one-year condition and the 50% revenue or 50% investment thresholds, and it includes a Regulation 74(5) compliance certificate for the quarter ended 30 September 2025. The next formal step implied by the text is the shareholder process for the name change, followed by ROC and stock exchange approvals and the associated documentation trail.